Financhill
Buy
66

EQX.TO Quote, Financials, Valuation and Earnings

Last price:
$21.14
Seasonality move :
6.94%
Day range:
$19.22 - $19.97
52-week range:
$7.71 - $23.49
Dividend yield:
0%
P/E ratio:
309.78x
P/S ratio:
3.43x
P/B ratio:
2.02x
Volume:
4.8M
Avg. volume:
2.8M
1-year change:
108.46%
Market cap:
$15.7B
Revenue:
$2.1B
EPS (TTM):
$0.06

EQX.TO Analysts' Consensus Rating

The 7 analysts providing 12-month price projections for Equinox Gold Corp. shares anticipate an average target of $14.20, ranging from a low estimate of $11.24 to a high estimate of $17.51. This average target implies a growth of -28.83% compared to the current stock price of $19.95.

Consensus Price Target

$14.20

Highest Price Target

$17.51

Lowest Price Target

$11.24

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 4 5 6

Hold 4 1 1

Sell 0 0 0
Consensus Leans Bullish Buy Buy

EQX.TO Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will UnitedHealth Stock Recover?
Will UnitedHealth Stock Recover?

Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…

Is Lumentum The Best Laser Stock to Buy?
Is Lumentum The Best Laser Stock to Buy?

Though certainly less well-known than the huge tech businesses that…

Is Planet Fitness Stock Undervalued?
Is Planet Fitness Stock Undervalued?

Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…

Stock Ideas

Buy
56
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
61
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
53
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 30x

Alerts

Sell
40
BILL alert for Feb 9

Bill Holdings, Inc. [BILL] is up 3.7% over the past day.

Buy
75
PRLB alert for Feb 9

Proto Labs, Inc. [PRLB] is down 2.16% over the past day.

Sell
30
MSTR alert for Feb 9

Strategy, Inc. [MSTR] is up 2.59% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock